Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
ORIC Pharmaceuticals, Inc.
Market Cap
$1.24B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.22B
Gross Margin
21.39%
TTM Avg
44.69%
3Y Avg
30.35%
5Y Avg
27.69%
Market Cap
$1.21B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.20B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.18B
Gross Margin
75.69%
TTM Avg
77.82%
3Y Avg
66.62%
5Y Avg
62.85%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ORIC Pharmaceuticals, Inc. (ORIC) | $1.24B | 0.00% | 0.00% | 0.00% | 0.00% |
| Omada Health (OMDA)vs › | $1.23B | 68.19% | 63.14% | 57.81% | 57.81% |
| Cronos Group Inc. (CRON)vs › | $1.23B | 36.16% | 31.39% | 23.56% | 1.95% |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 21.39% | 44.69% | 30.35% | 27.69% |
| Tyra Biosciences, Inc. (TYRA)vs › | $1.21B | 0.00% | 0.00% | 0.00% | 0.00% |
| Kardigan, Inc. (KARD)vs › | $1.21B | 0.00% | 0.00% | 0.00% | 0.00% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.20B | 0.00% | 0.00% | 0.00% | 0.00% |
| MannKind Corporation (MNKD)vs › | $1.18B | 75.69% | 77.82% | 66.62% | 62.85% |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.31B | 0.00% | 0.00% | 0.00% | 0.00% |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.33B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
